The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) in routine clinical practice, with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01357668?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
